Streptococcus group B (GBS)--characteristic, occurrence in children and adolescents with type 1 diabetes mellitus

Maria Nowakowska1, Przemysława Jarosz-Chobot

  • 1Chair and Department of Microbiology, Silesian Medical University, Katowice. mhnowakowska@wp.pl

Insights

Group B Streptococcus (GBS) colonization is more frequent in children and adolescents with type 1 diabetes, particularly those with poor metabolic control. This highlights a potential risk factor for GBS infections in this vulnerable population.

Area of Science:

  • Microbiology
  • Pediatrics
  • Endocrinology

Background:

  • Group B Streptococcus (GBS) is a significant pathogen causing infections in pregnant women, newborns, and adults, often associated with underlying conditions like diabetes mellitus.
  • Type 1 diabetes mellitus is a common predisposing factor for infections, necessitating an understanding of specific bacterial colonization patterns in affected children and adolescents.
  • The carrier state of GBS in individuals with diabetes may increase the risk of developing invasive GBS infections.

Purpose of the Study:

  • To determine the frequency of Group B Streptococcus (GBS) occurrence in children and adolescents diagnosed with type 1 diabetes mellitus.
  • To assess the antibiotic susceptibility of GBS strains isolated from this pediatric diabetic population.
  • To investigate the correlation between GBS colonization and metabolic control in children and adolescents with type 1 diabetes.

Main Methods:

  • A cross-sectional study was conducted between 2000-2002 involving 161 diabetic children/adolescents (5-17 years) and 37 children in a control group.
  • Clinical samples (urine, pharyngeal, and urogenital swabs) were collected to detect GBS.
  • Antibiotic susceptibility testing was performed on isolated GBS strains against ampicillin, erythromycin, and clindamycin.

Main Results:

  • GBS was detected in 22.4% of diabetic children (36/161), with higher prevalence in girls (27.8%) than boys (15.5%).
  • GBS occurrence was significantly higher in diabetic children with insufficient metabolic control or longer diabetes duration (p=0.029).
  • All GBS isolates (40 strains) were susceptible to penicillins, but resistance or moderate sensitivity was noted for erythromycin (4/40) and clindamycin (3/40).

Conclusions:

  • Children and adolescents with type 1 diabetes mellitus exhibit a higher frequency of GBS colonization compared to non-diabetic controls.
  • Poor metabolic control is associated with increased GBS carriage in this population, indicating a potential risk factor for GBS infections.
  • While penicillin remains effective, monitoring antibiotic resistance patterns for erythromycin and clindamycin is crucial for GBS management in diabetic pediatric patients.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...